TELA Bio, Inc.
TELA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 18.6% | 41.1% | 40.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.1% | 68.6% | 65.3% | 63.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -45.7% | -69.5% | -94.3% | -98.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -54.6% | -79.8% | -106.9% | -112.9% |
| EPS Diluted | -1.33 | -2.04 | -2.73 | -2.3 |
| % Growth | 34.8% | 25.3% | -18.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |